Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edit Varkondi"'
Autor:
Judita Szkukalek, Róbert Dóczi, Anna Dirner, Ákos Boldizsár, Ágnes Varga, Júlia Déri, Dóra Lakatos, Dóra Tihanyi, Barbara Vodicska, Richárd Schwáb, Gábor Pajkos, Edit Várkondi, István Vályi-Nagy, Dorottya Valtinyi, Zsuzsanna Nagy, István Peták
Publikováno v:
Diagnostics, Vol 11, Iss 10, p 1850 (2021)
Background: We present the case of a 50-year-old female whose metastatic pancreatic neuroendocrine tumor (pNET) diagnosis was delayed by the COVID-19 pandemic. The patient was in critical condition at the time of diagnosis due to the extensive tumor
Externí odkaz:
https://doaj.org/article/7ab3b8fd1ec74cd3a1932c4cb7cb1cdb
Autor:
Diána Brauswetter, Bianka Gurbi, Attila Varga, Edit Várkondi, Richárd Schwab, Gábor Bánhegyi, Orsolya Fábián, György Kéri, István Vályi-Nagy, István Peták
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185687 (2017)
Pancreatic cancer is an increasing cause of cancer related death worldwide. KRAS is the dominant oncogene in this cancer type and molecular rationale would indicate, that inhibitors of the downstream target MEK could be appropriate targeted agents, b
Externí odkaz:
https://doaj.org/article/a86dc0d78bea4e2a92e9c631ca56458e
Autor:
Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi, Odette Mariani, Peter Filotas, Anne Salomon, Barbara Vodicska, Vincent Servois, Edit Varkondi, David Gentien, Dora Tihanyi, Patricia Tresca, Dora Lakatos, Nicolas Servant, Julia Deri, Pauline du Rusquec, Csilla Hegedus, Diana Bello Roufai, Richard Schwab, Celia Dupain, Istvan T. Valyi-Nagy, Christophe Le Tourneau
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Precision oncology is currently based on pairing molecularly targeted agents (MTA) to predefined single driver genes or biomarkers. Each tumor harbors a combination of a large number of potential genetic alterations of multiple driver genes
Externí odkaz:
https://doaj.org/article/25368c6568c249e3961734d462c71641